e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study
Agostoni P., Banfi C., Brioschi M., Magrì D., Sciomer S., Berna G., Brambillasca C., Marenzi G., Sisillo E.
Source:
Eur Respir J 2011; 37: 841-847
Journal Issue:
April
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Agostoni P., Banfi C., Brioschi M., Magrì D., Sciomer S., Berna G., Brambillasca C., Marenzi G., Sisillo E.. Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study. Eur Respir J 2011; 37: 841-847
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Surfactant protein expression at various COPD Gold stages
Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury
Related content which might interest you:
Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation
Source: Eur Respir J 2011; 37: 925-932
Year: 2011
Cardiopulmonary effects of iloprost in experimental acute lung injury
Source: Eur Respir J 2005; 25: 81-87
Year: 2005
Strategies to reverse lung function deterioration to cardiopulmonary bypass: Comparison of ventilation management and/or bronchodilator therapies
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016
Combined application of lung recruitment maneuver and surfactant administration for the treatment of ARDS after operation on heart
Source: Annual Congress 2008 - Acute lung injury and weaning
Year: 2008
Sevoflurane improves lung function impairment induced by cardiopulmonary bypass in cardiac surgery patients
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013
Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery
Source: Eur Respir J 2006; 27: 1026-1032
Year: 2006
Mechanisms responsible for surfactant changes in sepsis-induced lung injury
Source: Eur Respir J 2005; 26: 1074-1079
Year: 2005
Effects of mechanical ventilation of isolated mouse lungs on surfactant and inflammatory cytokines
Source: Eur Respir J 2001; 17: 488-494
Year: 2001
Strategies in the prevention and the treatment of ischaemia-reperfusion injury after lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=66
Year: 2004
The use of surfactant in severe reperfusion injury after lung transplantation
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005
Impact of preoperative pulmonary perfusion on lung function changes following cardiopulmonary bypass (CPB) and aortic clamping
Source: Annual Congress 2007 - Clinical applications of lung function testing in children
Year: 2007
Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation},
Source: Eur Respir J 2012; 40: 837-843
Year: 2012
The influence of lung volume reduction surgery on exercise in patients with COPD
Source: Eur Respir J 2004; 23: 269-274
Year: 2004
Surfactant therapy for post-bypass lung injury
Source: Eur Respir J 2002; 20: Suppl. 38, 35s
Year: 2002
Short-term effects of surfactant administration on regional lung function in a model of ventilator-induced lung injury (VILI) in rabbit
Source: International Congress 2014 – Respiratory pathophysiology: mechanisms of alteration of lung, respiratory and peripheral muscle function
Year: 2014
Effects of anesthesia, muscle paralysis and controlled ventilation on gas exchanges evaluated by DLCO and pulmonary surfactant protein B: Preliminary results
Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation
Year: 2012
The role of the acute phase protein PTX3 in the ventilator-induced lung injury
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007
The value of capnogram parameters to detect adverse lung mechanical changes following cardiopulmonary bypass
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016
Prevention of increased surfactant degradation in acute lung injury
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009
Airflow limitation, lung volumes and systemic inflammation in a general population
Source: Eur Respir J 2011; 39: 29-37
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept